366efb6edf84e4e560c290ea4df17ab0.38UoTaGT3eJWSKb8jw1qZ244oxvzWYkV7DZ4WXNIkJg.6o1-OevwkZZlONGvzH0pHRxN2l_FOP5UmnwgMAsn0qnutxl8lsuurgIQ4w
01:01am Genentech and Roche Present New Data Across Pharmaceuticals and Diagnostics From Its Growing Alzheimer’s Disease Portfolio at CTAD 2026 BU
11-04 Roche 'Comfortable' with Consensus Giredestrant Sales Ahead of Launch, Berenberg Says MT
11-04 Roche Holding AG : Berenberg reiterates its Neutral rating ZD
11-02 Roche Diagnostics Announces FDA 510(k) Clearance for Cobas Eplex Respiratory Pathogen Panel 3 CI
11-02 Roche Falls After UBS Downgrade, Despite Raised TP Zonebourse
11-02 Roche Holding AG : UBS is less optimistic ZD
10-28 Roche Announces Global Launch Of Ventana BAP1 Test For Differential Diagnosis Of Mesothelioma CI
10-28 Roche Holding AG : Receives a Buy rating from Deutsche Bank ZD
10-28 DKSH Holding AG Acquires the Rights for Rocephin from Roche Across More Than 80 Markets CI
10-27 DKSH Holding AG acquired rights for Rocephin from Roche Holding AG. CI
10-27 Roche's New Immunoassay Testing Platform Receives CE Mark MT
10-26 Swiss Blue-chip Index Starts Week Upbeat; Roche Gains Amid Positive Lung Cancer Drug Trial MT
10-26 Roche Holding AG : JP Morgan reaffirms its Neutral rating ZD
10-25 Roche says divarasib cut risk of death 44% in lung cancer trial RE
10-25 Roche Targets Emerging Oncology Market With New Lung-Cancer Drug DJ
10-25 Genentech’s Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer BU
10-23 Roche Presents Interim Phase Iii Data Showing Sefaxersen Significantly Reduces Proteinuria in People with Iga Nephropathy CI
10-23 Genentech Presents Interim Phase III Data Showing Sefaxersen Significantly Reduced Proteinuria in People With IgA Nephropathy (IgAN) BU
10-23 Roche Holding AG : RBC reiterates its Buy rating ZD
10-23 Roche Holding AG : UBS reiterates its Buy rating ZD
10-23 Roche Holding AG : Receives a Sell rating from Jefferies ZD
10-23 Deutsche Bank Research Upgrades Roche to Buy, Boosts PT MT
10-23 Roche Holding AG : Goldman Sachs reiterates its Neutral rating ZD
10-23 Roche Holding AG : Deutsche Bank takes a positive view ZD
10-23 RBC Updates Model for Roche After 'Solid' Q3 Results MT

Become a member to access more news

New member
No results match your criteria